- Home
- DTST vs XLO Comparison
DTST vs XLO Comparison
Compare DTST & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTST
- XLO
- Stock Information
- Founded
- DTST 2001
- XLO 2016
- Country
- DTST United States
- XLO United States
- Employees
- DTST N/A
- XLO N/A
- Industry
- DTST EDP Services
- XLO Biotechnology: Pharmaceutical Preparations
- Sector
- DTST Technology
- XLO Health Care
- Exchange
- DTST Nasdaq
- XLO Nasdaq
- Market Cap
- DTST 32.6M
- XLO 35.7M
- IPO Year
- DTST N/A
- XLO 2021
- Fundamental
- Price
- DTST $4.19
- XLO $0.84
- Analyst Decision
- DTST Hold
- XLO Buy
- Analyst Count
- DTST 1
- XLO 2
- Target Price
- DTST N/A
- XLO $3.00
- AVG Volume (30 Days)
- DTST 66.7K
- XLO 407.5K
- Earning Date
- DTST 11-13-2025
- XLO 11-06-2025
- Dividend Yield
- DTST N/A
- XLO N/A
- EPS Growth
- DTST N/A
- XLO N/A
- EPS
- DTST N/A
- XLO N/A
- Revenue
- DTST $25,455,742.00
- XLO $15,001,000.00
- Revenue This Year
- DTST $12.57
- XLO $519.70
- Revenue Next Year
- DTST $9.29
- XLO $44.57
- P/E Ratio
- DTST N/A
- XLO N/A
- Revenue Growth
- DTST 0.53
- XLO 536.45
- 52 Week Low
- DTST $2.93
- XLO $0.62
- 52 Week High
- DTST $5.44
- XLO $1.70
- Technical
- Relative Strength Index (RSI)
- DTST 40.05
- XLO 59.67
- Support Level
- DTST $4.10
- XLO $0.79
- Resistance Level
- DTST $4.42
- XLO $0.85
- Average True Range (ATR)
- DTST 0.15
- XLO 0.04
- MACD
- DTST -0.02
- XLO 0.00
- Stochastic Oscillator
- DTST 20.81
- XLO 44.85
About DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.
About XLO Xilio Therapeutics Inc.
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).